Compare Nuvalent Inc (NUVL) vs Paychex, Inc. (PAYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvalent Inc vs Paychex, Inc. — how do they compare? Nuvalent Inc trades at $123.96 (market cap $9.81B), while Paychex, Inc. trades at $115.19 (market cap $40.98B). The key difference: Paychex, Inc. is far larger — about 4.2× Nuvalent Inc's market cap, and Paychex, Inc. pays a 4.13% dividend while Nuvalent Inc pays none. Which is the better fit depends on your goals.
| NUVL | PAYX | |
|---|---|---|
Market Cap | $9.81B | $40.98B |
Sector | Technology | Industrials |
52-Week High | $123.96 | $147.99 |
52-Week Low | $72.16 | $85.57 |
Enterprise Value | $8.52B | $44.47B |
Dividend Yield | — | 4.13% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuvalent Inc
Nuvalent, Inc. is a clinical-stage oncology company focused on creating precisely targeted therapies for patients with cancers driven by specific gene mutations. The company leverages a deep understanding of structural biology and medicinal chemistry to design novel small-molecule kinase inhibitors to overcome resistance mechanisms in advanced solid tumors. Nuvalent is committed to developing its pipeline of candidates to address high unmet needs in the treatment of various cancers.
Read more on NUVL →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
